The Progress Test of the European Hematology Association: A New Tool for Continuous Learning
Mariëlle J. Wondergem(Amsterdam UMC Location Vrije Universiteit Amsterdam), Gunnar Birgegård(Uppsala University Hospital), Bas T. Hemker(Cito (Netherlands)), Carlos Fernández de Larrea(Hospital Clínic de Barcelona), Janaki Brolin(Karlstad Central Hospital), António Almeida(Hospital da Luz), Wietske W.G. Hollegien(European Hematology Association), Nathalie van Havre(European Hematology Association), Alicia Rovó(University Hospital of Bern), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Mahesh Prahladan(University of Cambridge)
Cited by 0
Related Papers
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
|Journal of Clinical Oncology|2012|461
Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms
|Journal of Clinical Oncology|2011|244